SheMed is transforming women's health by offering accessible and personalized test-to-treat solutions designed particularly for women.
SheMed has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
SheMed is headquartered in London, United Kingdom.
SheMed is transforming women's health by offering accessible and personalized test-to-treat solutions designed particularly for women.
SheMed is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SheMed — Funding & Investors." VCBacked, October 23, 2025, https://www.vcbacked.co/company/shemed. Accessed August 14, 2026.
VCBacked. (2025). SheMed — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/shemed
{{cite web |title=SheMed — Funding & Investors |url=https://www.vcbacked.co/company/shemed |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated